Volume 12 - Issue 3 - March, 2015
03/03/2015
Dr. Andrej Schmidt, MD, senior interventionalist at the University Clinic of Leipzig in Germany, discusses results from a single-center study using paclitaxel-coated drug-eluting balloons for infrapopliteal lesions.
Dr. Andrej Schmidt, MD, senior interventionalist at the University Clinic of Leipzig in Germany, discusses results from a single-center study using paclitaxel-coated drug-eluting balloons for infrapopliteal lesions.
Dr. Andrej Schmidt, MD, senior...
03/03/2015
Vascular Disease Management
03/03/2015
Tsuyoshi Isawa, MD1; Kenji Suzuki, MD1; Hideki Abe, MD2
1Sendai Kousei Hospital, Sendai, Japan; 2Sanyudo Hospital, Yonezawa, Japan
Tsuyoshi Isawa, MD1; Kenji Suzuki, MD...
The authors describe the case of an 82-year-old Japanese male with acute upper limb ischemia (AULI) secondary to acute axillary artery occlusion caused by a proximal humeral fracture. He was successfully treated with endovascular therapy....
The authors describe the case of an 82-year-old Japanese male with acute upper limb ischemia (AULI) secondary to acute axillary artery occlusion caused by a proximal humeral fracture. He was successfully treated with endovascular therapy....
The authors describe the case of...
03/03/2015
Vascular Disease Management
03/03/2015
Drug-eluting balloon therapy is poised to improve patency of interventional therapy of superficial femoral and popliteal arterial obstructions.
Drug-eluting balloon therapy is poised to improve patency of interventional therapy of superficial femoral and popliteal arterial obstructions.
Drug-eluting balloon therapy is...
03/03/2015
Vascular Disease Management
03/03/2015
Drug-eluting balloon therapy is poised to improve patency of interventional therapy of superficial femoral and popliteal arterial obstructions.
Drug-eluting balloon therapy is poised to improve patency of interventional therapy of superficial femoral and popliteal arterial obstructions.
Drug-eluting balloon therapy is...
03/03/2015
Vascular Disease Management
Insights
Interview
03/03/2015
Jeffrey Lawson, MD
Duke University, Durham, North Carolina
Jeffrey Lawson, MD
Duke ...
Jeffrey Lawson, MD, of Duke University, discusses engineering of an implantable blood vessel from donor vascular cells. The technology has received US Food and Drug Administration fast-track designation for approval, and clinical trials are...
Jeffrey Lawson, MD, of Duke University, discusses engineering of an implantable blood vessel from donor vascular cells. The technology has received US Food and Drug Administration fast-track designation for approval, and clinical trials are...
Jeffrey Lawson, MD, of Duke...
03/03/2015
Vascular Disease Management
Feature
Case Report
03/03/2015
Faiz D. Francis, DO; Gianvito Salerno, MD; Sabbah D. Butty, MD
Indiana University, Indianapolis, Indiana
Faiz D. Francis, DO; Gianvito Salerno...
In this case, the authors present unassisted suction thrombectomy with percutaneously placed cannulae as an effective and safe method for the treatment of permanent IVC filter-related iliocaval thrombosis in cases refractory to...
In this case, the authors present unassisted suction thrombectomy with percutaneously placed cannulae as an effective and safe method for the treatment of permanent IVC filter-related iliocaval thrombosis in cases refractory to...
In this case, the authors...
03/03/2015
Vascular Disease Management
